Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

44.4%

4 terminated/withdrawn out of 9 trials

Success Rate

55.6%

-31.0% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

N/A
5(55.6%)
Phase 4
4(44.4%)
9Total
N/A(5)
Phase 4(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)